President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps ...

GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis.

TCA-101 is under clinical development by TCR Cure Biopharma Technology and currently in Phase II for Solid Tumor.

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Even before Trump enters the White House, the planet is showing worrying vital signs with scientists virtually certain 2024 ...